HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
Earnings for HTG Molecular Diagnostics (HTGM)
Earnings in 2023 (TTM): -$19.53 M
According to HTG Molecular Diagnostics 's latest financial reports the company's current earnings (TTM) are -$19.53 M. In 2022 the company made an earning of -$20.76 M a decrease over its 2021 earnings that were of -$16.06 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for HTG Molecular Diagnostics from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$19.53 M | -5.95% |
| 2022 | -$20.76 M | 29.27% |
| 2021 | -$16.06 M | -19.03% |
| 2020 | -$19.84 M | 8.15% |
| 2019 | -$18.34 M | 16.45% |
| 2018 | -$15.75 M | -10.89% |
| 2017 | -$17.68 M | -26.93% |
| 2016 | -$24.19 M | 20.34% |
| 2015 | -$20.1 M | 51.64% |
| 2014 | -$13.26 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | -$0.18 B | 807.20% | 🇺🇸 USA |
 Affimed
AFMD | -$0.12 B | 488.46% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | -$39.65 M | 103.09% | 🇺🇸 USA |